...
How can I take part?

...
ReDIRECT funders & partners

...
ReDIRECT news

Background

Long COVID is a multi-system condition that affects approximately 10% of people following COVID-19 infection.  There are several possible explanations for Long COVID, including persistent viral infection, an autoimmune response, micro-clots, and inflammation. As weight loss is known to have anti-inflammatory benefits, the ReDIRECT study aims to test whether an evidence-based weight loss programme can help alleviate symptoms of Long COVID in people who are overweight.

The study is run by the University of Glasgow, and we are looking for people interested in taking part. If you live in the UK, are over 18 years old, are experiencing symptoms of Long COVID, and are overweight (with a BMI of greater than 27kg/m²), then please get in touch with our study team for further information